AR071425A1 - Productos que comprenden acidos fenolicos descarboxilados derivados de acidos clorogenicos de cafe, y sus usos - Google Patents

Productos que comprenden acidos fenolicos descarboxilados derivados de acidos clorogenicos de cafe, y sus usos

Info

Publication number
AR071425A1
AR071425A1 ARP090101574A ARP090101574A AR071425A1 AR 071425 A1 AR071425 A1 AR 071425A1 AR P090101574 A ARP090101574 A AR P090101574A AR P090101574 A ARP090101574 A AR P090101574A AR 071425 A1 AR071425 A1 AR 071425A1
Authority
AR
Argentina
Prior art keywords
acids
products
chlorogenic
decarboxilated
cafe
Prior art date
Application number
ARP090101574A
Other languages
English (en)
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of AR071425A1 publication Critical patent/AR071425A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F5/00—Coffee; Coffee substitutes; Preparations thereof
    • A23F5/02—Treating green coffee; Preparations produced thereby
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/38—Other non-alcoholic beverages
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Child & Adolescent Psychology (AREA)

Abstract

Usos del ácido fenolico descarboxilado derivado de ácido clorogénico de café así como los productos que comprenden ácido fenolico descarboxilado derivado de ácido clorogénico de café, especialmente un extracto de café, y a los métodos para producir tales productos. El café comprende ácidos clorogénicos, de acuerdo con la presente estos ácidos clorogénicos pueden ser transformados en ácidos fenolicos descarboxilados. Los ácidos fenolicos descarboxilados resultantes poseen propiedades antioxidantes y/o anti-inflamatorias y se pueden utilizar como ingredientes en productos alimenticios y de bebida y para tratar ciertas condiciones de salud.
ARP090101574A 2008-04-30 2009-04-30 Productos que comprenden acidos fenolicos descarboxilados derivados de acidos clorogenicos de cafe, y sus usos AR071425A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08155434 2008-04-30

Publications (1)

Publication Number Publication Date
AR071425A1 true AR071425A1 (es) 2010-06-16

Family

ID=39769342

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090101574A AR071425A1 (es) 2008-04-30 2009-04-30 Productos que comprenden acidos fenolicos descarboxilados derivados de acidos clorogenicos de cafe, y sus usos

Country Status (24)

Country Link
US (1) US20110046235A1 (es)
EP (1) EP2282642B1 (es)
JP (1) JP5504254B2 (es)
KR (1) KR20110008200A (es)
CN (1) CN102014648A (es)
AR (1) AR071425A1 (es)
AU (1) AU2009242334B2 (es)
BR (1) BRPI0910839A2 (es)
CA (1) CA2723054C (es)
CL (1) CL2009001030A1 (es)
CO (1) CO6280591A2 (es)
ES (1) ES2425691T3 (es)
HR (1) HRP20130882T1 (es)
MX (1) MX2010011060A (es)
MY (1) MY161337A (es)
PE (1) PE20100129A1 (es)
PL (1) PL2282642T3 (es)
PT (1) PT2282642E (es)
RU (1) RU2010148751A (es)
TW (1) TW200944132A (es)
UA (1) UA103765C2 (es)
UY (1) UY31797A (es)
WO (1) WO2009132889A1 (es)
ZA (1) ZA201008552B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA111058C2 (uk) * 2009-12-18 2016-03-25 Нестек С.А. Спосіб одержання кавового екстракту із необсмажених зерен кави
WO2012013762A2 (en) * 2010-07-30 2012-02-02 Nestec S.A. Use of green coffee and probiotic for regulating skin pigmentation
EP2454945A1 (en) * 2010-11-12 2012-05-23 Nestec S.A. Methods of improving mental or physical health conditions in an individual
KR101060203B1 (ko) 2011-03-16 2011-08-29 김인재 커피 원두의 가공 방법 및 이에 의하여 제조된 커피 원두
US9034410B2 (en) * 2011-08-22 2015-05-19 Thomas J. Vella Whole green coffee bean products and methods of production and use
WO2013042811A1 (ko) * 2011-09-22 2013-03-28 (주)바이오에프디엔씨 카페오일알파네오엔돌핀 펩타이드 유도체 및 이의 항가려움 및 항아토피 소재로의 활용
EP2659782A1 (en) * 2012-05-04 2013-11-06 Nestec S.A. Methods of improving mental or health conditions
RU2648367C2 (ru) * 2012-12-28 2018-03-26 Нестек С.А. Пенообразующее средство и способ его приготовления
KR101584632B1 (ko) 2013-12-11 2016-01-12 한국벡스팜제약 주식회사 배변 활동을 향상시키는 커피 조성물
JP6709587B2 (ja) * 2014-10-21 2020-06-17 丸善製薬株式会社 皮膚化粧料および頭髪化粧料
JP6981685B2 (ja) * 2014-10-21 2021-12-17 丸善製薬株式会社 皮膚化粧料、頭髪化粧料および飲食品
JP6666650B2 (ja) * 2014-10-21 2020-03-18 丸善製薬株式会社 皮膚化粧料、頭髪化粧料および飲食品
JP6396760B2 (ja) * 2014-10-31 2018-09-26 花王株式会社 睡眠の質改善具
US10526621B2 (en) * 2015-04-09 2020-01-07 Soceite Des Produits Nestle S.A. Method of forming dihydroferulic acid
KR101661173B1 (ko) 2015-04-13 2016-09-29 강림중공업 주식회사 냉각구조의 소형 증발가스 처리장치용 연소기
KR101661172B1 (ko) 2015-04-13 2016-09-29 강림중공업 주식회사 증발가스 처리장치용 가스연소기
KR101661169B1 (ko) 2015-04-13 2016-09-29 강림중공업 주식회사 증발가스 처리장치용 가스연소기
KR20170032815A (ko) * 2015-09-15 2017-03-23 경희대학교 산학협력단 신규 유산균 및 퇴행성 뇌질환 또는 인지기능의 예방, 개선 또는 치료용 조성물
JP6946039B2 (ja) * 2016-04-08 2021-10-06 高砂香料工業株式会社 酢酸含有飲食品組成物
JP6517968B2 (ja) * 2018-03-12 2019-05-22 花王株式会社 睡眠改善剤
JP6993628B2 (ja) * 2019-01-30 2022-01-13 丸善製薬株式会社 皮膚化粧料、頭髪化粧料および飲食品
JP6993627B2 (ja) * 2019-01-30 2022-01-13 丸善製薬株式会社 皮膚化粧料、頭髪化粧料および飲食品
JP7253263B2 (ja) 2020-03-17 2023-04-06 丸善製薬株式会社 皮膚化粧料、頭髪化粧料および飲食品
JP2023530076A (ja) * 2020-06-17 2023-07-13 ソシエテ・デ・プロデュイ・ネスレ・エス・アー コーヒー生豆の脱カフェイン処理に由来するサイドストリーム生成物によるｌｃ－ｐｕｆａの安定化

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3949100A (en) * 1972-04-13 1976-04-06 Firmenich & Cie Flavoring agent
GB9004348D0 (en) * 1990-02-27 1990-04-25 Orion Yhtymae Oy New use of catechol derivatives and their physiologically acceptable salts and esters
JP2983386B2 (ja) * 1992-07-21 1999-11-29 長谷川香料株式会社 飲食品用フレーバー劣化防止剤及びその利用
JP2000502104A (ja) * 1995-12-21 2000-02-22 スミスクライン・ビーチャム・コーポレイション エンドセリン受容体アンタゴニスト
US5997929A (en) 1997-11-03 1999-12-07 Nestec S.A. Extraction process
DE19832245A1 (de) 1998-07-17 2000-01-20 Heidelberger Druckmasch Ag Verfahren zum Bedienen von Geräten in der Reproduktionstechnik
GB9903216D0 (en) * 1999-02-13 1999-04-07 Zylepsis Ltd Preservative compounds,compositions and methods of making and using the same
EP1078576A1 (en) 1999-08-23 2001-02-28 Société des Produits Nestlé S.A. Coffee aroma recovery process
NL1013477C2 (nl) 1999-11-03 2001-05-04 Vermaat Technics Bv Werkwijze en inrichting voor het lassen van pijpen.
US20020160067A1 (en) 2001-04-25 2002-10-31 Oncology Science Corporation Therapeutic preparation and method for producing a therapeutic preparation using coffee beans as a substrate
US6458392B1 (en) * 2000-07-12 2002-10-01 Kao Corporation Preventive, alleviative or remedy for hypertension
US20030003212A1 (en) * 2001-06-13 2003-01-02 Givaudan Sa Taste modifiers
GB0215343D0 (en) 2002-07-03 2002-08-14 Kvaerner Process Systems As Sand transport system
JP4812222B2 (ja) * 2002-11-26 2011-11-09 花王株式会社 ミネラル吸収促進剤
DE60220554T2 (de) * 2002-12-19 2008-02-14 Council Of Scientific & Industrial Research Mikrowelleninduzierter prozess zur herstellung von substituierten 4-vinylphenolen
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
US20050031761A1 (en) * 2003-08-05 2005-02-10 Donald Brucker Methods of producing a functionalized coffee
WO2005032570A1 (ja) * 2003-10-06 2005-04-14 Oryza Oil & Fat Chemical Co., Ltd. ダイエット用組成物
JP2006020526A (ja) 2004-07-06 2006-01-26 Kiyomitsu Kawasaki コーヒーフレーバー組成物および該フレーバー組成物を含有する飲食品類
EP1712137A1 (en) * 2005-04-12 2006-10-18 Nestec S.A. Coffee product
JP4873444B2 (ja) * 2005-06-03 2012-02-08 日本たばこ産業株式会社 血液凝固遅延剤
CA2582969A1 (en) 2006-03-21 2007-09-21 National Research Council Of Canada Process for producing 4-vinylguaiacol by biodecarboxylation of ferulic acid
CN101057678B (zh) * 2007-06-13 2010-09-01 深圳市金沙江投资有限公司 一种含有天然植物提取物或单体的组合物
JP5162212B2 (ja) * 2007-11-19 2013-03-13 丸善製薬株式会社 新規乳酸菌、乳酸菌組成物及び植物エキス、並びに、植物エキス及び低分子ポリフェノールの製造方法

Also Published As

Publication number Publication date
UY31797A (es) 2009-11-10
CL2009001030A1 (es) 2010-06-11
AU2009242334B2 (en) 2014-05-01
EP2282642A1 (en) 2011-02-16
JP5504254B2 (ja) 2014-05-28
MY161337A (en) 2017-04-14
UA103765C2 (uk) 2013-11-25
JP2011518570A (ja) 2011-06-30
AU2009242334A1 (en) 2009-11-05
CO6280591A2 (es) 2011-05-20
PT2282642E (pt) 2013-08-27
ES2425691T3 (es) 2013-10-16
RU2010148751A (ru) 2012-06-10
WO2009132889A1 (en) 2009-11-05
US20110046235A1 (en) 2011-02-24
EP2282642B1 (en) 2013-07-24
CA2723054C (en) 2016-12-13
PE20100129A1 (es) 2010-03-02
HRP20130882T1 (hr) 2013-10-25
CN102014648A (zh) 2011-04-13
TW200944132A (en) 2009-11-01
BRPI0910839A2 (pt) 2015-07-28
ZA201008552B (en) 2012-05-30
MX2010011060A (es) 2010-11-22
CA2723054A1 (en) 2009-11-05
KR20110008200A (ko) 2011-01-26
PL2282642T3 (pl) 2013-12-31

Similar Documents

Publication Publication Date Title
AR071425A1 (es) Productos que comprenden acidos fenolicos descarboxilados derivados de acidos clorogenicos de cafe, y sus usos
CO6280593A2 (es) Metodo de produccion de un extracto de cafe por hidrolisis de acidos clorogenicos
MY166016A (en) Infant nutrition for improving fatty acid composition of brain membranes
PH12016502050A1 (en) Homovanillinic acid ester, in particular, for creating a hot and/or pungent taste sensation
BR112014029077A2 (pt) composições e métodos para aumentar a estabilidade de aditivos para produto alimentar
GB2507448A (en) Process for the production of a liquid coffee concentrate
MX2016016995A (es) Composiciones de acido fitico, magnesio y polifenoles y su aplicacion para la prevencion de la litiasis renal oxalocalcica.
NZ703633A (en) Solid agave syrup compositions
BR112012016054A2 (pt) Composições nutricionais compreendendo flocos de fruta incluindo ácido docosa-hexaenoico
MX2015012205A (es) Productos de leche humana altos en grasa.
BR112017003945A2 (pt) composição de gordura comestível
MX2017003660A (es) Composicion nutricional que se usa para promover la maduracion y/o reparacion del intestino y/o del higado.
NZ627671A (en) Des(rhamnosyl) acteoside-containing olive extract
BR112019005396A2 (pt) essência de água natural e métodos para produzir a mesma
MX2018007724A (es) Composicion farmaceutica para tratamiento de hiperplasia prostatica.
MX2015015787A (es) Capsulas para la liberacion de aroma.
CL2014001519A1 (es) Ingrediente antioxidante de bajo contenido calórico, procedimiento de obtención y uso.
CO6592032A2 (es) Extracto de café que comprende un ion multivalente
MY169916A (en) Milk-containing coffee beverage with little coffee lipid content
MX363686B (es) Capsulas de aceite de cafe.
NZ717532A (en) A combination barbecue
WO2012108745A3 (ko) 조각인 추출물을 포함하는 뇌암 치료용 조성물 및 건강 기능성 식품
WO2012108744A3 (ko) 선복화 추출물을 포함하는 뇌암 치료용 조성물 및 건강 기능성 식품
WO2017188759A3 (ko) 특정 플라보노이드 및 폴리페놀 화합물 함량이 증진된 헛개나무 추출물의 제조방법
AR105629A1 (es) Composición que comprende compuestos para la modulación del sabor, su uso y alimentos que la comprenden

Legal Events

Date Code Title Description
FB Suspension of granting procedure